| Bioactivity | Elosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome[1]. |
| Name | Elosulfase alfa |
| CAS | 9025-60-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sanford M, et al. Elosulfase alfa: first global approval. Drugs. 2014 Apr;74(6):713-8. |